PubMed registered articles post 2006 Institute for Cancer Genetics and Informatics

Publications published since 2006 from OUS - Institute for Cancer Genetics and Informatics

478 publications found

Publications 2026

1. Brunetti M, Andersen K, Lobmaier I, Micci F (2026)
   Identification of the HMGA2::CIBAR1-DT fusion transcript in two lipomas with chromosomal rearrangements involving chromosomes 8 and 12
   Front Oncol, 15, 1717031
   DOI 10.3389/fonc.2025.1717031, PubMed 41568362
2. Hannisdal MH, Lundervold A, Goplen D, Brekke J, Rahman MA, Brandal P, Solheim TS, Lie SA, Blaser N, Chekenya M (2026)
   Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology
   NPJ Precis Oncol (in press)
   DOI 10.1038/s41698-026-01557-0, PubMed 42286261
3. Heggebø LC, Johannessen TA, Magelssen H, Sprauten M, Blakstad H, Brekke J, Goplen D, Marienhagen K, Solheim TS, Bjorland L, Brandal P (2026)
   Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy
   Clin Transl Radiat Oncol, 58, 101140
   DOI 10.1016/j.ctro.2026.101140, PubMed 41798870
4. Julbø FMI, Henriksen AL, Pradhan M, Lindstrøm EK, Kostolomov I, Oukrif D, van der Schee L, Isaksen MX, Manet A, Skrede OJ, De Raedt S, Liestøl K, Askautrud HA, Eide TJ, Holme Ø, Kerr DJ, Shepherd NA, Lacle MM, Novelli M, Hveem TS, Kleppe A (2026)
   Reliable classification of polyps based on artificial intelligence: a development and validation study
   EClinicalMedicine, 93, 103826
   DOI 10.1016/j.eclinm.2026.103826, PubMed 41859674
5. Kalsnes J, Isaksen MX, Julbø F, Pradhan M, Kleppe A, De Raedt S, Skrede OJ, Torheim T, Nesheim JA, Mohn HM, Askautrud HA, Cyll K, Kildal W, Rewcastle E, Lillesand M, Kvikstad V, Janssen E, Jones R, Brustugun OT, Brennhovd B, Haug ES, Busund LR, Richardsen E, Andersen S, Dønnem T et al. (2026)
   Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study
   FEBS Open Bio, 16 (7), 1259-1270
   DOI 10.1002/2211-5463.70210, PubMed 41676879
6. Kasius JC, Kildal W, Vrede SW, Pijnenborg JMA, Kleppe A (2026)
   Response to letter Re: Surgical stage in the era of molecular profiling of endometrial cancer
   Eur J Cancer, 236, 116268
   DOI 10.1016/j.ejca.2026.116268, PubMed 41637855
7. Kildal W, Pradhan M, Kristensen GB, Vlatkovic L, Tobin KAR, Hveem TS, Lindemann K, Askautrud HA, Kleppe A (2026)
   Prognostic role of estrogen receptor, L1 cell adhesion molecule, and tumor grade in patients with endometrial carcinoma of no specific molecular profile
   Int J Gynecol Cancer, 36 (5), 104669
   DOI 10.1016/j.ijgc.2026.104669, PubMed 41990404
8. Panagopoulos I, Lobmaier I (2026)
   Novel MYH11::GLI3 fusion in ileal leiomyoma
   Pathol Oncol Res, 32, 1612375
   DOI 10.3389/pore.2026.1612375, PubMed 42051689
9. Schöb FJ, Binder A, Zamarian V, Sordi V, Scholz H, Malthe-Sørenssen A, Dysthe DK (2026)
   Deep learning for predicting stem cell efficiency for use in beta cell differentiation
   Sci Rep, 16 (1)
   DOI 10.1038/s41598-026-42830-3, PubMed 41803201
10. Singleton AH, Manet A, Valvo S, Feenstra M, Stenmark H, Dustin ML, Kvalvaag A (2026)
    isMap - immunological synapse map analysis program
    Front Immunol, 17, 1746651
    DOI 10.3389/fimmu.2026.1746651, PubMed 41859117
11. Skrede OJ, Pradhan M, Isaksen MX, Hveem TS, Vlatkovic L, Nesbakken A, Lindemann K, Kristensen GB, Kasius J, Zeimet AG, Brustugun OT, Busund LR, Richardsen EH, Haug ES, Brennhovd B, Rewcastle E, Lillesand M, Kvikstad V, Janssen E, Kerr DJ, Liestøl K, Albregtsen F, Kleppe A (2026)
    Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types
    NPJ Precis Oncol, 10 (1)
    DOI 10.1038/s41698-026-01311-6, PubMed 41634087

Publications 2025

1. Andersen K, Tjønnfjord GE, Hestdalen ML, Spetalen S, Panagopoulos I (2025)
   Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOM Rearrangement, SF3B1 Mutation, and Transient TNIP1::PDGFRB Chimera
   Cancer Genomics Proteomics, 22 (1), 24-33
   DOI 10.21873/cgp.20483, PubMed 39730178
2. Brunetti M, Andersen K, Spetalen S, Tjønnfjord GE, Heim S, Micci F (2025)
   Cryptic Rearrangement of the KMT2A Gene in a B-cell Acute Lymphoblastic Leukemia
   Anticancer Res, 45 (3), 921-928
   DOI 10.21873/anticanres.17479, PubMed 40037847
3. Brunetti M, Gjelberg HK, Reikvam H, Micci F (2025)
   Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia
   Front Oncol, 15, 1658257
   DOI 10.3389/fonc.2025.1658257, PubMed 40933896
4. Brunetti M, Vitelli V, Naas AM, Zahl Eriksson AG, Haugland HK, Krakstad C, Micci F (2025)
   Molecular Landscape of Endometrial Stromal Tumors
   JCO Precis Oncol, 9, e2400779
   DOI 10.1200/PO-24-00779, PubMed 40403211
5. Cyll K, Skrede OJ, Kleppe A (2025)
   Can radiology be first to use prognostic deep learning models for oncological treatment?
   Ann Oncol, 36 (10), 1119-1122
   DOI 10.1016/j.annonc.2025.07.013, PubMed 40754034
6. Deng K, Pällmann N, Livgård M, Kildal W, Pradhan M, Fazli L, Rennie PS, Jin Y, Saatcioglu F, Kuzu OF (2025)
   Endoplasmic reticulum stress-driven nucleotide catabolism fuels prostate cancer
   Cancer Lett, 630, 217888
   DOI 10.1016/j.canlet.2025.217888, PubMed 40617554
7. Ebner C, Lindemann K, Kristensen G, Frosch A, Askautrud H, Di Santo G, Leitner K, Marth C, Zeimet AG (2025)
   Are brain metastases a special issue in POLE-mutated endometrial cancer? a case report series
   Front Oncol, 15, 1568137
   DOI 10.3389/fonc.2025.1568137, PubMed 40958870
8. Emblem KE, Ringstad G, Svensson SF, Vatnehol SAS, Storås TH, Vik-Mo EO, Heggebø LC, Brandal P, Eide PK (2025)
   Intrathecal contrast-enhanced MRI reveals an alternative route for drug delivery and brain tumor visualization
   Cancer Lett, 638, 218152
   DOI 10.1016/j.canlet.2025.218152, PubMed 41276108
9. Furtner J, Berchtold L, Le Rhun E, Silvani A, Rudà R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Sahm F, Wick W, Minniti G, Weller M, König F, Preusser M (2025)
   Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trial
   Neurooncol Adv, 7 (1), vdaf152
   DOI 10.1093/noajnl/vdaf152, PubMed 40735273
10. Heggebø LC, Borgen IMH, Blakstad H, Saxhaug C, Rønning PA, Niehusmann PF, Werlenius K, Blomstrand M, Brandal P (2025)
    Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
    Front Oncol, 15, 1397912
    DOI 10.3389/fonc.2025.1397912, PubMed 39949738
11. Heggebø LC, Garrote FLB, Fjæra LF, Hervani M, Ramberg C, Ottestad A, Blakstad H, Martens T, Rueegg CS, Gustavsson M, Henry T, Blomstrand M, Hellebust TP, Brandal P (2025)
    Protons or Photons in Pituitary Neuroendocrine Tumors-That Is Not the Question
    Int J Part Ther, 17, 101194
    DOI 10.1016/j.ijpt.2025.101194, PubMed 40678408
12. Kasius JC, Kildal W, Vrede SW, Askautrud HA, Pradhan M, van Altena AM, Tobin KR, Knoll K, Reijnen C, Reimann S, Dackus G, Vlatkovic L, Huvila J, Steinlechner M, Tubita V, Gil-Moreno A, Snijders MPLM, Vos MC, Hveem TS, Asberger J, Zeimet AG, Matias-Guiu X, Lindemann K, Weinberger V, Visser NCM et al. (2025)
    Surgical stage in the era of molecular profiling of endometrial cancer
    Eur J Cancer, 233, 116164
    DOI 10.1016/j.ejca.2025.116164, PubMed 41385938
13. Kato K, Panagopoulos I, Yoshimi A, Ikenobe N, Kobayashi C, Goto H, Ito M, Sagisaka M, Andersen K, Noda A, Tamai M, Akahane K, Inukai T, Ohki K, Kiyokawa N, Tsuchida M (2025)
    Establishment and characterization of a novel cell line ICH-BCPALL-3 from B cell precursor acute lymphoblastic leukemia with TCF3::HLF
    Hum Cell, 39 (1), 11
    DOI 10.1007/s13577-025-01318-4, PubMed 41258531
14. Kuzu OF, Granerud LJT, Saatcioglu F (2025)
    Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations
    Signal Transduct Target Ther, 10 (1), 358
    DOI 10.1038/s41392-025-02439-w, PubMed 41130962
15. Panagopoulos I, Andersen K, Lloret I, Gorunova L, Lobmaier I (2025)
    Novel FRMD6::PTH chimera in tumorous bone lesion carrying a t(4;11;14;12)(q35;p15;q22;q13)
    Pathol Oncol Res, 31, 1612096
    DOI 10.3389/pore.2025.1612096, PubMed 40641561
16. Pradhan M, Kildal W, Vlatkovic L, Tobin KAR, Lindemann K, Kristensen GB, Kleppe A, Askautrud HA (2025)
    Prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma
    Int J Gynecol Cancer, 35 (7), 101915
    DOI 10.1016/j.ijgc.2025.101915, PubMed 40409205
17. Pradhan M, Kildal W, Vlatkovic L, Tobin KAR, Lindemann K, Kristensen GB, Kleppe A, Askautrud HA (2025)
    Response to correspondence on prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma by Pradhan et al
    Int J Gynecol Cancer, 35 (7), 101970
    DOI 10.1016/j.ijgc.2025.101970, PubMed 40592175
18. Rounge TB, Paulsen J (2025)
    Highly sensitive method captures rare RNAs in blood to search for disease
    Nature, 641 (8063), 599-600
    DOI 10.1038/d41586-025-01127-7, PubMed 40240820
19. Tjønnfjord EB, Tveten K, Spetalen S, Tjønnfjord GE (2025)
    ANKRD26 Gene Mutation and Thrombocytopenia-Is the Risk of Malignancy Dependent on the Mutation Variant?
    Hematol Rep, 17 (4)
    DOI 10.3390/hematolrep17040037, PubMed 40863182
20. Trewin-Nybråten CB, Lambert PC, Marienhagen K, Andreassen L, Johannesen TB, Niehusmann P, Oltedal L, Schipmann S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Brandal P, Ingebrigtsen T, Skaga E, advisory board for the Norwegian Brain and Spinal Cord Tumour Registry (2025)
    Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry
    J Neurooncol, 175 (3), 1355-1366
    DOI 10.1007/s11060-025-05218-3, PubMed 40932639
21. Unal B, Saatcioglu F (2025)
    Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppression
    Biomark Res, 13 (1), 156
    DOI 10.1186/s40364-025-00813-y, PubMed 41372991
22. Xiao W, Chen Q, Liu C, Yu Y, Liu T, Jin Y, Ma H, Chen S, Jiang C (2025)
    Gut microbiota in cancer: From molecular mechanisms to precision medicine applications
    Imeta, 4 (2), e70017
    DOI 10.1002/imt2.70017, PubMed 40236776

Publications 2024

1. Andersen K, Tjønnfjord GE, Ramslien LF, Panagopoulos I (2024)
   RUNX1::MIR99AHG Chimera in Acute Myeloid Leukemia
   Genes Chromosomes Cancer, 63 (9), e23272
   DOI 10.1002/gcc.23272, PubMed 39324493
2. Behsen AD, Holien T, Micci F, Rye M, Rasmussen JM, Andersen K, Hess ES, Børset M, Keats J, Våtsveen TK, Misund K (2024)
   Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy
   Sci Rep, 14 (1), 28805
   DOI 10.1038/s41598-024-80263-y, PubMed 39567630
3. Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
   The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
   J Neurooncol, 169 (1), 137-145
   DOI 10.1007/s11060-024-04709-z, PubMed 38762830
4. Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes LTN, Vålerhaugen H, Heim S, Micci F (2024)
   NUP214 fusion genes in acute leukemias: genetic characterization of rare cases
   Front Oncol, 14, 1371980
   DOI 10.3389/fonc.2024.1371980, PubMed 38571499
5. Brunetti M, Andersen K, Trøen G, Micci F, Spetalen S, Lenartova A, Tandsæther MR, Panagopoulos I (2024)
   Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10)
   Front Oncol, 14, 1428984
   DOI 10.3389/fonc.2024.1428984, PubMed 39391249
6. Cyll K, Skaaheim Haug E, Pradhan M, Vlatkovic L, Carlsen B, Löffeler S, Kildal W, Skogstad K, Hauge Torkelsen F, Syvertsen RA, Askautrud HA, Liestøl K, Kleppe A, Danielsen HE (2024)
   DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance
   Br J Cancer, 131 (5), 895-904
   DOI 10.1038/s41416-024-02780-x, PubMed 38961192
7. Feroz B, Pan TL, Leitner K, Ebner C, Steger K, Kildal W, Kristensen G, Zeimet AG, Hackl H, Fiegl H, Marth C, Wieser V (2024)
   Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome
   Int J Gynecol Cancer, 34 (11), 1711-1718
   DOI 10.1136/ijgc-2023-005188, PubMed 38969503
8. Frei AL, McGuigan A, Sinha RRAK, Jabbar F, Gneo L, Tomasevic T, Harkin A, Iveson T, Saunders MP, Oien KA, Maka N, Pezzella F, Campo L, Browne M, Glaire M, Kildal W, Danielsen HE, Hay J, Edwards J, Sansom O, Kelly C, Tomlinson I, Kerr R, Kerr D, Domingo E et al. (2024)
   Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
   Lancet Oncol, 25 (2), 198-211
   DOI 10.1016/S1470-2045(23)00560-0, PubMed 38301689
9. Halldorsson S, Nagymihaly RM, Patel A, Brandal P, Panagopoulos I, Leske H, Lund-Iversen M, Sahm F, Vik-Mo EO (2024)
   Accurate and comprehensive evaluation of O6-methylguanine-DNA methyltransferase promoter methylation by nanopore sequencing
   Neuropathol Appl Neurobiol, 50 (3), e12984
   DOI 10.1111/nan.12984, PubMed 38783575
10. Hansen SB, Unal B, Kuzu OF, Saatcioglu F (2024)
    Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease management
    Theranostics, 14 (18), 6913-6934
    DOI 10.7150/thno.100555, PubMed 39629128
11. Hatchett WJ, Brunetti M, Andersen K, Tandsæther MR, Lobmaier I, Lund-Iversen M, Lien-Dahl T, Micci F, Panagopoulos I (2024)
    Genetic characterization of intramuscular myxomas
    Pathol Oncol Res, 30, 1611553
    DOI 10.3389/pore.2024.1611553, PubMed 38317844
12. Heggebø LC, Blakstad H, Eriksson MC, Brandal P (2024)
    Lomustine overdose in a patient with diffuse glioma: symptoms, management and outcome
    BMJ Case Rep, 17 (7)
    DOI 10.1136/bcr-2024-260450, PubMed 39043464
13. Kenseth A, Kantorova D, Seo MK, Aas E, Cairns J, Kerr D, Askautrud H, Jacobsen JE (2024)
    Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?
    Pharmacoeconomics, 42 (6), 679-691
    DOI 10.1007/s40273-024-01371-1, PubMed 38584239
14. Kildal W, Cyll K, Kalsnes J, Islam R, Julbø FM, Pradhan M, Ersvær E, Shepherd N, Vlatkovic L, OSBREAC, Tekpli X, Garred Ø, Kristensen GB, Askautrud HA, Hveem TS, Danielsen HE, OSBREAC - Oslo Breast Cancer Consortium (2024)
    Deep learning for automated scoring of immunohistochemically stained tumour tissue sections - Validation across tumour types based on patient outcomes
    Heliyon, 10 (13), e32529
    DOI 10.1016/j.heliyon.2024.e32529, PubMed 39040241
15. Kleppe A, Lindemann K, Kildal W, Tobin KAR, Pradhan M, Vlatkovic L, Isaksen MX, Danielsen HE, Askautrud HA, Kristensen GB (2024)
    Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer
    Gynecol Oncol, 192, 80-88
    DOI 10.1016/j.ygyno.2024.11.005, PubMed 39549540
16. Korkmaz A, Bernhardsen GP, Cirit B, Koprucu Suzer G, Kayan H, Biçmen H, Tahra M, Suner A, Lehto SM, Sag D, Saatcioglu F (2024)
    Sudarshan Kriya Yoga Breathing and a Meditation Program for Burnout Among Physicians: A Randomized Clinical Trial
    JAMA Netw Open, 7 (1), e2353978
    DOI 10.1001/jamanetworkopen.2023.53978, PubMed 38294813
17. Lindemann K, Kildal W, Kleppe A, Tobin KAR, Pradhan M, Isaksen MX, Vlatkovic L, Danielsen HE, Kristensen GB, Askautrud HA (2024)
    Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer
    Eur J Cancer, 200, 113584
    DOI 10.1016/j.ejca.2024.113584, PubMed 38330767
18. Lindemann K, Kildal W, Kleppe A, Tobin KAR, Pradhan M, Mascialino B, Schneider D, Edvardsen H, Sørlie T, Kristensen GB, Askautrud HA (2024)
    Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapy
    Int J Gynecol Cancer, 35 (5), 101618
    DOI 10.1016/j.ijgc.2024.101618, PubMed 40189984
19. Panagopoulos I, Andersen K, Gorunova L, Lobmaier I (2024)
    Fusion of Platelet Derived Growth Factor Receptor Alpha (PDGFRA) With Ubiquitin Specific Peptidase 8 (USP8) in a Calcified Chondroid Mesenchymal Neoplasm Harboring t(4;15)(q12;q21) as a Sole Aberration
    Cancer Genomics Proteomics, 21 (3), 252-259
    DOI 10.21873/cgp.20444, PubMed 38670591
20. Panagopoulos I, Andersen K, Johannsdottir IMR, Tandsæther MR, Micci F, Heim S (2024)
    Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL)
    Cancer Genomics Proteomics, 21 (1), 1-11
    DOI 10.21873/cgp.20424, PubMed 38151288
21. Panagopoulos I, Andersen K, Lobmaier I, Lund-Iversen M (2024)
    Genetic Heterogeneity in Cellular Angiofibromas
    Genes Chromosomes Cancer, 63 (8), e23262
    DOI 10.1002/gcc.23262, PubMed 39120141
22. Panagopoulos I, Andersen K, Stavseth V, Torkildsen S, Heim S, Tandsæther MR (2024)
    Germline MYOF1::WNK4 and VPS25::MYOF1 Chimeras Generated by the Constitutional Translocation t(17;19)(q21;p13) in Two Siblings With Myelodysplastic Syndrome
    Cancer Genomics Proteomics, 21 (3), 272-284
    DOI 10.21873/cgp.20446, PubMed 38670586
23. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR (2024)
    Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome
    Anticancer Res, 44 (4), 1389-1397
    DOI 10.21873/anticanres.16935, PubMed 38537997
24. Prasad PJR, Fretland AA, Albregtsen F, Elle OJ, Kumar RP (2024)
    Transfer Learning with Interpretability: Liver Segmentation in CT and MR using Limited Dataset
    Annu Int Conf IEEE Eng Med Biol Soc, 2024, 1-5
    DOI 10.1109/EMBC53108.2024.10782042, PubMed 40039644
25. Prysiazhniuk Y, Server A, Leske H, Bech-Aase Ø, Helseth E, Eijgelaar RS, Fuster-García E, Brandal P, Bjørnerud A, Otáhal J, Petr J, Nordhøy W (2024)
    Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study
    Neurooncol Adv, 6 (1), vdae113
    DOI 10.1093/noajnl/vdae113, PubMed 39036439
26. Sheng X, Nenseth HZ, Qu S, Kuzu OF, Frahnow T, Simon L, Greene S, Zeng Q, Fazli L, Rennie PS, Mills IG, Danielsen H, Theis F, Patterson JB, Jin Y, Saatcioglu F (2024)
    Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling
    Nat Commun, 15 (1), 6190
    DOI 10.1038/s41467-024-50645-x, PubMed 39043728
27. Skaga E, Trewin-Nybråten CB, Niehusmann P, Johannesen TB, Marienhagen K, Oltedal L, Schipman S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Petter Brandal, Ingebrigtsen T (2024)
    Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study
    Acta Oncol, 63, 83-94
    DOI 10.2340/1651-226X.2024.24970, PubMed 38501768
28. Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M (2024)
    3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
    Neuro Oncol, 26 (7), 1302-1309
    DOI 10.1093/neuonc/noae037, PubMed 38452246
29. Tauziède-Espariat A, Nicaise Y, Sievers P, Sahm F, von Deimling A, Guillemot D, Pierron G, Duchesne M, Edjlali M, Dangouloff-Ros V, Boddaert N, Roux A, Dezamis E, Hasty L, Lhermitte B, Hirsch E, Hirsch MPV, Ardellier FD, Karnoub MA, Csanyi M, Maurage CA, Mokhtari K, Bielle F, Rigau V, Roujeau T et al. (2024)
    CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
    Acta Neuropathol Commun, 12 (1), 55
    DOI 10.1186/s40478-023-01695-7, PubMed 38581034
30. Unal B, Kuzu OF, Jin Y, Osorio D, Kildal W, Pradhan M, Kung SHY, Oo HZ, Daugaard M, Vendelbo M, Patterson JB, Thomsen MK, Kuijjer ML, Saatcioglu F (2024)
    Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
    Nat Commun, 15 (1), 8895
    DOI 10.1038/s41467-024-53039-1, PubMed 39406723
31. Wiig JN, Dagenborg VJ, Larsen SG (2024)
    Ten-year survival and pattern of recurrence in patients with locally recurrent rectal or sigmoid cancer undergoing resection
    Colorectal Dis, 27 (1) (in press)
    DOI 10.1111/codi.17226, PubMed 39635974
32. Zhang T, Zhao F, Lin Y, Liu M, Zhou H, Cui F, Jin Y, Chen L, Sheng X (2024)
    Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression
    Theranostics, 14 (3), 1065-1080
    DOI 10.7150/thno.92336, PubMed 38250042
33. Zhao F, Zhang T, Wei J, Chen L, Liu Z, Jin Y, Liu M, Zhou H, Hu Y, Sheng X (2024)
    Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression
    EBioMedicine, 109, 105398
    DOI 10.1016/j.ebiom.2024.105398, PubMed 39418984

Publications 2023

1. Bakke KM, Meltzer S, Grøvik E, Negård A, Holmedal SH, Mikalsen LTG, Færden AE, Lyckander LG, Julbø FMI, Bjørnerud A, Gjesdal KI, Ree AH, Redalen KR (2023)
   Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcome
   Phys Imaging Radiat Oncol, 25, 100417
   DOI 10.1016/j.phro.2023.100417, PubMed 36718357
2. Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, Lie SA, Chekenya M, Goplen D (2023)
   Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
   PLoS One, 18 (2), e0281166
   DOI 10.1371/journal.pone.0281166, PubMed 36730349
3. Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
   Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
   Neurooncol Pract, 11 (1), 36-45
   DOI 10.1093/nop/npad063, PubMed 38222046
4. Boye K, Gorunova L, Gunawan B, Hompland I, Sander B, Panagopoulos I, Langer C, Golas M, Heim S, Füzesi L, Hølmebakk T, Micci F (2023)
   Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor
   JCO Precis Oncol, 7, e2200351
   DOI 10.1200/PO.22.00351, PubMed 36724411
5. Eide PK, Lindstrøm EK, Pripp AH, Valnes LM, Ringstad G (2023)
   Physiological alterations of pineal recess crowding in symptomatic non-hydrocephalic pineal cysts
   Brain Commun, 5 (2), fcad078
   DOI 10.1093/braincomms/fcad078, PubMed 37501910
6. Frei AL, McGuigan A, Sinha RR, Glaire MA, Jabbar F, Gneo L, Tomasevic T, Harkin A, Iveson TJ, Saunders M, Oein K, Maka N, Pezella F, Campo L, Hay J, Edwards J, Sansom OJ, Kelly C, Tomlinson I, Kildal W, Kerr RS, Kerr DJ, Danielsen HE, Domingo E, TransSCOT Consortium et al. (2023)
   Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets
   J Pathol Clin Res, 9 (6), 449-463
   DOI 10.1002/cjp2.342, PubMed 37697694
7. Gjelberg HK, Helgeland L, Liseth K, Micci F, Sandnes M, Russnes HG, Reikvam H (2023)
   Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature
   Curr Oncol, 30 (11), 10007-10018
   DOI 10.3390/curroncol30110727, PubMed 37999147
8. Grisham RN, Vergote I, Banerjee S, Drill E, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Cibula D, Moore KN, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C, Kristensen G et al. (2023)
   Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
   Clin Cancer Res, 29 (20), 4068-4075
   DOI 10.1158/1078-0432.CCR-23-0621, PubMed 37581616
9. Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
   Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
   BMJ Open, 13 (3), e070071
   DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
10. Isaksen KT, Galleberg R, Mastroianni MA, Rinde M, Rusten LS, Barzenje D, Ramslien F, Fluge O, Slaaen M, Meyer P, Liestol K, Smeland EB, Lingjarde OC, Holte H, Brodtkorb M (2023)
    The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy
    Haematologica, 108 (9), 2454-2466
    DOI 10.3324/haematol.2022.282289, PubMed 36861406
11. Karamouza E, Glasspool RM, Kelly C, Lewsley LA, Carty K, Kristensen GB, Ethier JL, Kagimura T, Yanaihara N, Cecere SC, You B, Boere IA, Pujade-Lauraine E, Ray-Coquard I, Proust-Lima C, Paoletti X (2023)
    CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data
    Cancers (Basel), 15 (6)
    DOI 10.3390/cancers15061823, PubMed 36980708
12. Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
    Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
    Neuropathology, 43 (5), 385-390
    DOI 10.1111/neup.12895, PubMed 36754566
13. Lindemann K, Heimisdottir Danbolt S, Ramberg L, Eyjólfsdóttir B, Wang YY, Heli-Haugestøl AG, Walcott SL, Mjåland O, Navestad GA, Hermanrud S, Juul-Hansen KE, Bragstad LK, Opheim R, Kleppe A, Kongsgaard U (2023)
    Patient-reported nausea after implementation of an enhanced recovery after surgery protocol for gynae-oncology patients
    Int J Gynecol Cancer, 33 (8), 1287-1294
    DOI 10.1136/ijgc-2023-004356, PubMed 37451689
14. Lindemann K, Kleppe A, Eyjólfsdóttir B, Heimisdottir Danbolt S, Wang YY, Heli-Haugestøl AG, Walcott SL, Mjåland O, Navestad GA, Hermanrud S, Juul-Hansen KE, Kongsgaard U (2023)
    Prospective evaluation of an enhanced recovery after surgery (ERAS) pathway in a Norwegian cohort of patients with suspected or advanced ovarian cancer
    Int J Gynecol Cancer, 33 (8), 1279-1286
    DOI 10.1136/ijgc-2023-004355, PubMed 37451690
15. Norén-Nyström U, Andersen MK, Barbany G, Dirse V, Eilert-Olsen M, Engvall M, Harila-Saari A, Heyman M, Hovland R, Häikiö S, Jónsson JJ, Karhu R, Kjeldsen E, Norberg A, Preiss BS, Pulkkinen K, Quist-Paulsen P, Räsänen H, Schmiegelow K, Seitsonen A, Sjögren H, Tammur P, Johansson B (2023)
    Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial
    Hemasphere, 7 (5), e883
    DOI 10.1097/HS9.0000000000000883, PubMed 37153872
16. Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Davidson B, Lund-Iversen M, Micci F, Heim S (2023)
    Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis
    Cancer Genomics Proteomics, 20 (4), 363-374
    DOI 10.21873/cgp.20388, PubMed 37400148
17. Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Kostolomov I, Kildal W, Hognestad HR, Lobmaier I, Micci F, Heim S (2023)
    Pathogenetic Dichotomy in Angioleiomyoma
    Cancer Genomics Proteomics, 20 (6), 556-566
    DOI 10.21873/cgp.20405, PubMed 37889065
18. Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Lund-Iversen M, Micci F, Heim S (2023)
    Fusion of the High-mobility Group AT-Hook 2 (HMGA2) and the Gelsolin (GSN) Genes in Lipomas With t(9;12)(q33;q14) Chromosomal Translocation
    In Vivo, 37 (2), 524-530
    DOI 10.21873/invivo.13110, PubMed 36881074
19. Panagopoulos I, Andersen K, Gorunova L, Hognestad HR, Pedersen TD, Lobmaier I, Micci F, Heim S (2023)
    Chromosome Translocation t(10;19)(q26;q13) in a CIC-sarcoma
    In Vivo, 37 (1), 57-69
    DOI 10.21873/invivo.13054, PubMed 36593014
20. Panagopoulos I, Andersen K, Gorunova L, Lund-Iversen M, Lobmaier I, Micci F, Heim S (2023)
    Recurrent 8q11-13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1, in Lipomatous Tumors
    Cancer Genomics Proteomics, 20 (2), 171-181
    DOI 10.21873/cgp.20372, PubMed 36870688
21. Panagopoulos I, Andersen K, Rinvoll Johannsdottir IM, Micci F, Heim S (2023)
    Novel MYCBP::EHD2 and RUNX1::ZNF780A Fusion Genes in T-cell Acute Lymphoblastic Leukemia
    Cancer Genomics Proteomics, 20 (1), 51-63
    DOI 10.21873/cgp.20364, PubMed 36581344
22. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR, Micci F, Heim S (2023)
    Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of HNRNPH1 With MLLT10
    Cancer Genomics Proteomics, 20 (4), 354-362
    DOI 10.21873/cgp.20387, PubMed 37400142
23. Panagopoulos I, Gorunova L, Lobmaier I, Heim S (2023)
    Fusion of the Genes for Interferon Regulatory Factor 2 Binding Protein 2 (IRF2BP2) and Caudal Type Homeobox 1 (CDX1) in a Chondrogenic Tumor
    In Vivo, 37 (6), 2459-2463
    DOI 10.21873/invivo.13352, PubMed 37905608
24. Valstad H, Eyjolfsdottir B, Wang Y, Kristensen GB, Skeie-Jensen T, Lindemann K (2023)
    Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis
    Eur J Surg Oncol, 49 (9), 106958
    DOI 10.1016/j.ejso.2023.06.010, PubMed 37349160
25. Yang L, Yang J, Kleppe A, Danielsen HE, Kerr DJ (2023)
    Personalizing adjuvant therapy for patients with colorectal cancer
    Nat Rev Clin Oncol, 21 (1), 67-79
    DOI 10.1038/s41571-023-00834-2, PubMed 38001356

Publications 2022

1. Blakstad H, Wohlleben C, Saxhaug C, Brandal P (2022)
   SMART syndrome: two cases highlighting a complex and rare complication of brain irradiation
   BMJ Case Rep, 15 (9)
   DOI 10.1136/bcr-2022-249599, PubMed 36167430
2. Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem TS, Davidson B, Eriksson AGZ, Trent PKB, Heim S, Micci F (2022)
   Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile
   Cancers (Basel), 14 (14)
   DOI 10.3390/cancers14143536, PubMed 35884597
3. Cyll K, Löffeler S, Carlsen B, Skogstad K, Plathan ML, Landquist M, Haug ES (2022)
   No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
   Sci Rep, 12 (1), 6743
   DOI 10.1038/s41598-022-10741-8, PubMed 35468921
4. Fusser M, Øverbye A, Pandya AD, Mørch Ý, Borgos SE, Kildal W, Snipstad S, Sulheim E, Fleten KG, Askautrud HA, Engebraaten O, Flatmark K, Iversen TG, Sandvig K, Skotland T, Mælandsmo GM (2022)
   Corrigendum to "Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft", [Journal of Control Release, 293 (2019) 183-192]
   J Control Release, 349, 1
   DOI 10.1016/j.jconrel.2022.06.040, PubMed 35792388
5. Gorunova L, Boye K, Panagopoulos I, Berner JM, Bjerkehagen B, Hompland I, Lobmaier I, Hølmebakk T, Hveem TS, Heim S, Micci F (2022)
   Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
   Oncotarget, 13, 508-517
   DOI 10.18632/oncotarget.28209, PubMed 35284037
6. Jin Y, Lorvik KB, Jin Y, Beck C, Sike A, Persiconi I, Kvaløy E, Saatcioglu F, Dunn C, Kyte JA (2022)
   Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer
   Mol Ther Oncolytics, 26, 189-206
   DOI 10.1016/j.omto.2022.06.007, PubMed 35860008
7. Kleppe A (2022)
   Area under the curve may hide poor generalisation to external datasets
   ESMO Open, 7 (2), 100429
   DOI 10.1016/j.esmoop.2022.100429, PubMed 35397433
8. Kleppe A, Skrede OJ, De Raedt S, Hveem TS, Askautrud HA, Jacobsen JE, Church DN, Nesbakken A, Shepherd NA, Novelli M, Kerr R, Liestøl K, Kerr DJ, Danielsen HE (2022)
   A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study
   Lancet Oncol, 23 (9), 1221-1232
   DOI 10.1016/S1470-2045(22)00391-6, PubMed 35964620
9. Knuth F, Groendahl AR, Winter RM, Torheim T, Negård A, Holmedal SH, Bakke KM, Meltzer S, Futsæther CM, Redalen KR (2022)
   Semi-automatic tumor segmentation of rectal cancer based on functional magnetic resonance imaging
   Phys Imaging Radiat Oncol, 22, 77-84
   DOI 10.1016/j.phro.2022.05.001, PubMed 35602548
10. Kristiansen O, Roland MC, Zucknick M, Reine TM, Kolset SO, Henriksen T, Lekva T, Michelsen T (2022)
    Maternal body mass index and placental weight: a role for fetal insulin, maternal insulin and leptin
    J Endocrinol Invest, 45 (11), 2105-2121
    DOI 10.1007/s40618-022-01842-2, PubMed 35781790
11. Kvammen JA, Stensvold E, Godang K, Bollerslev J, Myklebust TÅ, Brandal P, Henriksen C, Bechensteen AG (2022)
    Bone mineral density and nutrition in long-term survivors of childhood brain tumors
    Clin Nutr ESPEN, 50, 162-169
    DOI 10.1016/j.clnesp.2022.05.025, PubMed 35871919
12. Marshall JL, Peshkin BN, Yoshino T, Vowinckel J, Danielsen HE, Melino G, Tsamardinos I, Haudenschild C, Kerr DJ, Sampaio C, Rha SY, FitzGerald KT, Holland EC, Gallagher D, Garcia-Foncillas J, Juhl H (2022)
    The Essentials of Multiomics
    Oncologist, 27 (4), 272-284
    DOI 10.1093/oncolo/oyab048, PubMed 35380712
13. Nainamalai V, Prasad PJR, Pelanis E, Edwin B, Albregtsen F, Elle OJ, P Kumar R (2022)
    Evaluation of clinical applicability of automated liver parenchyma segmentation of multi-center magnetic resonance images
    Eur J Radiol Open, 9, 100448
    DOI 10.1016/j.ejro.2022.100448, PubMed 36386761
14. Nilsen A, Hillestad T, Skingen VE, Aarnes EK, Fjeldbo CS, Hompland T, Evensen TS, Stokke T, Kristensen GB, Grallert B, Lyng H (2022)
    miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
    Mol Oncol, 16 (6), 1402-1419
    DOI 10.1002/1878-0261.13184, PubMed 35064630
15. Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S (2022)
    A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality
    Cancer Genomics Proteomics, 19 (5), 636-646
    DOI 10.21873/cgp.20348, PubMed 35985686
16. Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S (2022)
    Fusion of the HMGA2 and BNC2 Genes in Uterine Leiomyoma With t(9;12)(p22;q14)
    In Vivo, 36 (6), 2654-2661
    DOI 10.21873/invivo.13000, PubMed 36309352
17. Panagopoulos I, Andersen K, Gorunova L, Eilert-Olsen M, Lund-Iversen M, Wessel-Aas T, Lloret I, Micci F, Heim S (2022)
    Presence of a t(12;18)(q14;q21) Chromosome Translocation and Fusion of the Genes for High-mobility Group AT-Hook 2 (HMGA2) and WNT Inhibitory Factor 1 (WIF1) in Infrapatellar Fat Pad Cells from a Patient With Hoffa's Disease
    Cancer Genomics Proteomics, 19 (5), 584-590
    DOI 10.21873/cgp.20343, PubMed 35985683
18. Panagopoulos I, Andersen K, Gorunova L, Lund-Iversen M, Lobmaier I, Heim S (2022)
    Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone
    Cancer Genomics Proteomics, 19 (2), 163-177
    DOI 10.21873/cgp.20312, PubMed 35181586
19. Panagopoulos I, Gorunova L, Andersen K, Lobmaier I, Micci F, Heim S (2022)
    Fusion of High Mobility Group AT-hook 2 Gene (HMGA2) With the Chromosome 12 Open Reading Frame 42 Gene (C12orf42) in an Aggressive Angiomyxoma With del(12)(q14q23) as the Sole Cytogenetic Anomaly
    Cancer Genomics Proteomics, 19 (5), 576-583
    DOI 10.21873/cgp.20342, PubMed 35985684
20. Panagopoulos I, Gorunova L, Andersen K, Lund-Iversen M, Hognestad HR, Lobmaier I, Micci F, Heim S (2022)
    Chromosomal Translocation t(5;12)(p13;q14) Leading to Fusion of High-mobility Group AT-hook 2 Gene With Intergenic Sequences From Chromosome Sub-Band 5p13.2 in Benign Myoid Neoplasms of the Breast: A Second Case
    Cancer Genomics Proteomics, 19 (4), 445-455
    DOI 10.21873/cgp.20331, PubMed 35732319
21. Panagopoulos I, Heim S (2022)
    Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation
    Cancer Genomics Proteomics, 19 (6), 647-672
    DOI 10.21873/cgp.20349, PubMed 36316036
22. Sikkeland J, Ng MYW, Nenseth HZ, Unal B, Qu S, Jin Y, Simonsen A, Saatcioglu F (2022)
    STAMP2 suppresses autophagy in prostate cancer cells by modulating the integrated stress response pathway
    Am J Cancer Res, 12 (1), 327-336
    PubMed 35141021
23. Skaga E, Kulesskiy E, Potdar S, Panagopoulos I, Micci F, Langmoen IA, Sandberg CJ, Vik-Mo EO (2022)
    Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome
    Transl Oncol, 26, 101535
    DOI 10.1016/j.tranon.2022.101535, PubMed 36115076
24. Saatcioglu F, Cirit B, Koprucu Suzer G (2022)
    The Promise of Well-Being Interventions to Mitigate Physician Burnout During the COVID-19 Pandemic and Beyond
    JCO Oncol Pract, 18 (12), 808-814
    DOI 10.1200/OP.22.00108, PubMed 36162039
25. Tanem KE, Stensvold E, Wilberg P, Skaare AB, Brandal P, Herlofson BB (2022)
    Oral and dental late effects in long-term survivors of childhood embryonal brain tumors
    Support Care Cancer, 30 (12), 10233-10241
    DOI 10.1007/s00520-022-07405-8, PubMed 36307656
26. Tanem KE, Stensvold E, Wilberg P, Skaare AB, Singh PB, Brandal P, Herlofson BB (2022)
    Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
    Support Care Cancer, 30 (7), 6155-6162
    DOI 10.1007/s00520-022-07048-9, PubMed 35426047
27. Tellez-Gabriel M, Tekpli X, Reine TM, Hegge B, Nielsen SR, Chen M, Moi L, Normann LS, Busund LR, Calin GA, Mælandsmo GM, Perander M, Theocharis AD, Kolset SO, Knutsen E (2022)
    Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue
    Front Oncol, 12, 868868
    DOI 10.3389/fonc.2022.868868, PubMed 35494005

Publications 2021

1. Cyll K, Kleppe A, Kalsnes J, Vlatkovic L, Pradhan M, Kildal W, Tobin KAR, Reine TM, Wæhre H, Brennhovd B, Askautrud HA, Skaaheim Haug E, Hveem TS, Danielsen HE (2021)
   PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer
   Cancers (Basel), 13 (17)
   DOI 10.3390/cancers13174291, PubMed 34503100
2. Deyab G, Reine TM, Vuong TT, Jenssen T, Hjeltnes G, Agewall S, Mikkelsen K, Førre Ø, Fagerland MW, Kolset SO, Hollan I (2021)
   Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
   PLoS One, 16 (7), e0253247
   DOI 10.1371/journal.pone.0253247, PubMed 34242246
3. Eide PK, Valnes LM, Lindstrøm EK, Mardal KA, Ringstad G (2021)
   Direction and magnitude of cerebrospinal fluid flow vary substantially across central nervous system diseases
   Fluids Barriers CNS, 18 (1), 16
   DOI 10.1186/s12987-021-00251-6, PubMed 33794929
4. Groendahl AR, Skjei Knudtsen I, Huynh BN, Mulstad M, Moe YM, Knuth F, Tomic O, Indahl UG, Torheim T, Dale E, Malinen E, Futsaether CM (2021)
   A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers
   Phys Med Biol, 66 (6), 065012
   DOI 10.1088/1361-6560/abe553, PubMed 33666176
5. Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2021)
   Bilateral calcification of the optic nerve sheath: A diagnostic dilemma
   Am J Ophthalmol Case Rep, 22, 101106
   DOI 10.1016/j.ajoc.2021.101106, PubMed 33997471
6. Isaksen KT, Mastroianni MA, Rinde M, Rusten LS, Barzenje DA, Ramslien LF, Slaaen M, Jerm MB, Smeland EB, Rostoft S, Liestøl K, Brodtkorb M, Holte H (2021)
   A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL
   Blood Adv, 5 (22), 4771-4782
   DOI 10.1182/bloodadvances.2021004777, PubMed 34543384
7. Jiang D, Hveem TS, Glaire M, Church DN, Kerr DJ, Yang L, Danielsen HE (2021)
   Automated assessment of CD8⁺ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer
   EBioMedicine, 71, 103547
   DOI 10.1016/j.ebiom.2021.103547, PubMed 34479131
8. Jones HJS, Cunningham C, Askautrud HA, Danielsen HE, Kerr DJ, Domingo E, Maughan T, Leedham SJ, Koelzer VH (2021)
   Stromal composition predicts recurrence of early rectal cancer after local excision
   Histopathology, 79 (6), 947-956
   DOI 10.1111/his.14438, PubMed 34174109
9. Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, Krakstad C, Werner HMJ, Amant F (2021)
   Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
   Cancers (Basel), 13 (22)
   DOI 10.3390/cancers13225848, PubMed 34831000
10. Kleppe A, Skrede OJ, De Raedt S, Liestøl K, Kerr DJ, Danielsen HE (2021)
    Designing deep learning studies in cancer diagnostics
    Nat Rev Cancer, 21 (3), 199-211
    DOI 10.1038/s41568-020-00327-9, PubMed 33514930
11. Kristiansen O, Zucknick M, Reine TM, Kolset SO, Jansson T, Powell TL, Haugen G, Henriksen T, Michelsen TM (2021)
    Mediators Linking Maternal Weight to Birthweight and Neonatal Fat Mass in Healthy Pregnancies
    J Clin Endocrinol Metab, 106 (7), 1977-1993
    DOI 10.1210/clinem/dgab166, PubMed 33713406
12. Körner SK, Dreyer T, Haug ES, Jerlström T, Boström PJ, Gudjonsson S, Jensen JB (2021)
    Which data are available in central registries on bladder cancer patients in the five Nordic countries
    Scand J Urol, 55 (2), 135-141
    DOI 10.1080/21681805.2021.1877344, PubMed 33504267
13. Liestøl K, Kleppe A, Skrede OJ, De Raedt S, Kerr DJ, Danielsen HE (2021)
    Deep learning and cancer biomarkers: recognising lead-time bias - Authors' reply
    Lancet, 397 (10270), 194-195
    DOI 10.1016/S0140-6736(21)00035-0, PubMed 33453777
14. Lindemann K, Smogeli E, Småstuen MC, Bruheim K, Trovik J, Nordberg T, Kristensen GB, Werner HMJ, Nakken E (2021)
    Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
    Cancers (Basel), 13 (6)
    DOI 10.3390/cancers13061367, PubMed 33803531
15. Liu MS, Zhao H, Xu CX, Xie PB, Wang W, Yang YY, Lee WH, Jin Y, Zhou HQ (2021)
    Clinical significance of EPHX2 deregulation in prostate cancer
    Asian J Androl, 23 (1), 109-115
    DOI 10.4103/aja.aja_34_20, PubMed 32687069
16. Nunes-Xavier CE, Kildal W, Kleppe A, Danielsen HE, Waehre H, Llarena R, Maelandsmo GM, Fodstad Ø, Pulido R, López JI (2021)
    Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer
    Prostate, 81 (12), 838-848
    DOI 10.1002/pros.24180, PubMed 34125445
17. Pandya AD, Iversen TG, Moestue S, Grinde MT, Mørch Ý, Snipstad S, Åslund AKO, Øy GF, Kildal W, Engebråten O, Sandvig K, Skotland T, Mælandsmo GM (2021)
    Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
    Nanomaterials (Basel), 11 (5)
    DOI 10.3390/nano11051140, PubMed 33924869
18. Pihlstrøm N, Jin Y, Nenseth Z, Kuzu OF, Saatcioglu F (2021)
    STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells
    Cancers (Basel), 13 (7)
    DOI 10.3390/cancers13071579, PubMed 33808059
19. Prasad PJR, Elle OJ, Lindseth F, Albregtsen F, Kumar RP (2021)
    Modifying U-Net for small dataset - a simplified U-Net version for Liver Parenchyma segmentation
    PROC SPIE, 11597, 115971O
    DOI 10.1117/12.2582179
20. Prasad PJR, Survarachakan S, Khan ZA, Lindseth F, Elle OJ, Albregtsen F, Kumar RP (2021)
    Numerical Evaluation on Parametric Choices Influencing Segmentation Results in Radiology Images-A Multi-Dataset Study
    Electronics, 10 (4), 431
    DOI 10.3390/electronics10040431
21. Pällmann N, Deng K, Livgård M, Tesikova M, Jin Y, Frengen NS, Kahraman N, Mokhlis HM, Ozpolat B, Kildal W, Danielsen HE, Fazli L, Rennie PS, Banerjee PP, Üren A, Jin Y, Kuzu OF, Saatcioglu F (2021)
    Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression
    Cancer Res, 81 (15), 4066-4078
    DOI 10.1158/0008-5472.CAN-20-3956, PubMed 34183356
22. Quiles-Jiménez A, Gregersen I, Segers FM, Skarpengland T, Kroustallaki P, Yang K, Kong XY, Lauritzen KH, Olsen MB, Karlsen TR, Nyman TA, Sagen EL, Bjerkeli V, Suganthan R, Nygård S, Scheffler K, Prins J, Van der Veer E, Øgaard JD, Fløisand Y, Jørgensen HF, Holven KB, Biessen EA, Nilsen H, Dahl TB et al. (2021)
    DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development
    Atherosclerosis, 324, 123-132
    DOI 10.1016/j.atherosclerosis.2021.02.023, PubMed 33714552
23. Rye IH, Huse K, Josefsson SE, Kildal W, Danielsen HE, Schlichting E, Garred Ø, Riis ML, Osbreac, Lingjaerde OC, Myklebust JH, Russnes HG (2021)
    Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression
    Mol Oncol, 16 (1), 88-103
    DOI 10.1002/1878-0261.13047, PubMed 34165864
24. Sert BM, Kristensen GB, Kleppe A, Dørum A (2021)
    Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience
    Gynecol Oncol, 162 (2), 284-291
    DOI 10.1016/j.ygyno.2021.05.028, PubMed 34083029
25. Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
    Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
    Acta Oncol, 61 (2), 235-238
    DOI 10.1080/0284186X.2021.2022202, PubMed 34970940

Publications 2020

1. Bindesbøll C, Aas A, Ogmundsdottir MH, Pankiv S, Reine T, Zoncu R, Simonsen A (2020)
   NBEAL1 controls SREBP2 processing and cholesterol metabolism and is a susceptibility locus for coronary artery disease
   Sci Rep, 10 (1), 4528
   DOI 10.1038/s41598-020-61352-0, PubMed 32161285
2. Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK (2020)
   T1 bladder cancer in Norway: treatment and survival
   Scand J Urol, 54 (5), 370-375
   DOI 10.1080/21681805.2020.1803401, PubMed 32783590
3. Brunetti M, Panagopoulos I, Kostolomov I, Davidson B, Heim S, Micci F (2020)
   Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancer
   Oncol Lett, 20 (3), 2273-2279
   DOI 10.3892/ol.2020.11782, PubMed 32782545
4. Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos Tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A et al. (2020)
   Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
   Genet Med, 22 (9), 1569
   DOI 10.1038/s41436-020-0892-4, PubMed 32690931
5. Ersvaer E, Hveem TS, Vlatkovic L, Brennhovd B, Kleppe A, Tobin KAR, Pradhan M, Cyll K, Waehre H, Kerr DJ, Danielsen HE (2020)
   Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer
   Int J Cancer, 147 (4), 1228-1234
   DOI 10.1002/ijc.32832, PubMed 31846064
6. Ferrante L, Opdal SH, Nygård S, Vege Å, Rognum TO (2020)
   Gene expression profile in cases of infectious death in infancy
   Pediatr Res, 89 (3), 483-487
   DOI 10.1038/s41390-020-0896-4, PubMed 32299088
7. Fjeldbo CS, Hompland T, Hillestad T, Aarnes EK, Günther CC, Kristensen GB, Malinen E, Lyng H (2020)
   Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
   EBioMedicine, 57, 102841
   DOI 10.1016/j.ebiom.2020.102841, PubMed 32580139
8. Hillestad T, Hompland T, Fjeldbo CS, Skingen VE, Salberg UB, Aarnes EK, Nilsen A, Lund KV, Evensen TS, Kristensen GB, Stokke T, Lyng H (2020)
   MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer
   Cancer Res, 80 (18), 3993-4003
   DOI 10.1158/0008-5472.CAN-20-0950, PubMed 32606004
9. Jin Y, Saatcioglu F (2020)
   Targeting the Unfolded Protein Response in Hormone-Regulated Cancers
   Trends Cancer, 6 (2), 160-171
   DOI 10.1016/j.trecan.2019.12.001, PubMed 32061305
10. Kleppe A, Albregtsen F, Trovik J, Kristensen GB, Danielsen HE (2020)
    Prognostic Value of the Diversity of Nuclear Chromatin Compartments in Gynaecological Carcinomas
    Cancers (Basel), 12 (12)
    DOI 10.3390/cancers12123838, PubMed 33352679
11. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2020)
    DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses
    Radiat Oncol, 15 (1), 79
    DOI 10.1186/s13014-020-01526-2, PubMed 32293487
12. Monk BJ, Grisham RN, Banerjee S, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Drill E, Cibula D, Moore KN, Christy-Bittel J, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C et al. (2020)
    MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
    J Clin Oncol, 38 (32), 3753-3762
    DOI 10.1200/JCO.20.01164, PubMed 32822286
13. Norell CH, Butler J, Farrell R, Altman A, Bentley J, Cabasag CJ, Cohen PA, Fegan S, Fung-Kee-Fung M, Gourley C, Hacker NF, Hanna L, Høgdall CK, Kristensen G, Kwon J, McNally O, Nelson G, Nordin A, O'Donnell D, Schnack T, Sykes PH, Zotow E, Harrison S (2020)
    Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care
    Int J Gynecol Cancer, 30 (11), 1748-1756
    DOI 10.1136/ijgc-2020-001403, PubMed 32784203
14. Panagopoulos I, Gorunova L, Kostolomov I, Lobmaier I, Bjerkehagen B, Heim S (2020)
    Chronic Expanding Hematoma with a t(11;19)(q13;q13) Chromosomal Translocation
    Anticancer Res, 40 (1), 97-100
    DOI 10.21873/anticanres.13930, PubMed 31892557
15. Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Kostolomov I, Lund-Iversen M, Bjerkehagen B, Heim S (2020)
    FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma
    Cancer Genomics Proteomics, 17 (2), 161-168
    DOI 10.21873/cgp.20176, PubMed 32108038
16. Skeie M, Nikolaysen F, Chitano Y, Stang E (2020)
    Hsp90 inhibition and co-incubation with pertuzumab induce internalization and degradation of trastuzumab: Implications for use of T-DM1
    J Cell Mol Med, 24 (17), 10258-10262
    DOI 10.1111/jcmm.15643, PubMed 32672902
17. Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestøl K, Maddison J, Askautrud HA, Pradhan M, Nesheim JA, Albregtsen F, Farstad IN, Domingo E, Church DN, Nesbakken A, Shepherd NA, Tomlinson I, Kerr R, Novelli M, Kerr DJ, Danielsen HE (2020)
    Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
    Lancet, 395 (10221), 350-360
    DOI 10.1016/S0140-6736(19)32998-8, PubMed 32007170
18. Woitek R, McLean MA, Gill AB, Grist JT, Provenzano E, Patterson AJ, Ursprung S, Torheim T, Zaccagna F, Locke M, Laurent MC, Hilborne S, Frary A, Beer L, Rundo L, Patterson I, Slough R, Kane J, Biggs H, Harrison E, Lanz T, Basu B, Baird R, Sala E, Graves MJ et al. (2020)
    Hyperpolarized ¹³C MRI of Tumor Metabolism Demonstrates Early Metabolic Response to Neoadjuvant Chemotherapy in Breast Cancer
    Radiol Imaging Cancer, 2 (4), e200017
    DOI 10.1148/rycan.2020200017, PubMed 32803167
19. Zhang T, Li N, Sun C, Jin Y, Sheng X (2020)
    MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?
    EMBO Mol Med, 12 (5), e11845
    DOI 10.15252/emmm.201911845, PubMed 32310340

Publications 2019

1. Binzer-Panchal A, Hardell E, Viklund B, Ghaderi M, Bosse T, Nucci MR, Lee CH, Hollfelder N, Corcoran P, Gonzalez-Molina J, Moyano-Galceran L, Bell DA, Schoolmeester JK, Måsbäck A, Kristensen GB, Davidson B, Lehti K, Isaksson A, Carlson JW (2019)
   Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
   Clin Cancer Res, 25 (7), 2155-2165
   DOI 10.1158/1078-0432.CCR-18-2792, PubMed 30617134
2. Brown P, , Zhou Y (2019)
   Large expert-curated database for benchmarking document similarity detection in biomedical literature search
   Database (Oxford), 2019
   DOI 10.1093/database/baz085, PubMed 33326193
3. Brunetti M, Agostini A, Staurseth J, Davidson B, Heim S, Micci F (2019)
   Molecular characterization of carcinosarcomas arising in the uterus and ovaries
   Oncotarget, 10 (38), 3614-3624
   DOI 10.18632/oncotarget.26942, PubMed 31217897
4. Brynildsen J, Petäjä L, Myhre PL, Lyngbakken MN, Nygård S, Stridsberg M, Christensen G, Ottesen AH, Pettilä V, Omland T, Røsjø H (2019)
   Circulating Secretoneurin Concentrations After Cardiac Surgery: Data From the FINNish Acute Kidney Injury Heart Study
   Crit Care Med, 47 (5), e412-e419
   DOI 10.1097/CCM.0000000000003670, PubMed 30730440
5. Braadland PR, Urbanucci A (2019)
   Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer
   Endocr Relat Cancer, 26 (4), R211-R235
   DOI 10.1530/ERC-18-0579, PubMed 30844748
6. Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos Tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A et al. (2019)
   Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
   Genet Med, 22 (1), 15-25
   DOI 10.1038/s41436-019-0596-9, PubMed 31337882
7. Ersvær E, Kildal W, Vlatkovic L, Cyll K, Pradhan M, Kleppe A, Hveem TS, Askautrud HA, Novelli M, Wæhre H, Liestøl K, Danielsen HE (2019)
   Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
   Mod Pathol, 33 (5), 905-915
   DOI 10.1038/s41379-019-0418-2, PubMed 31801961
8. Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN (2019)
   Tumour-infiltrating CD8⁺ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
   Br J Cancer, 121 (6), 474-482
   DOI 10.1038/s41416-019-0540-4, PubMed 31388185
9. Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN (2019)
   Correction: Tumour-infiltrating CD8⁺ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
   Br J Cancer, 121 (9), 807
   DOI 10.1038/s41416-019-0590-7, PubMed 31548598
10. Itkonen HM, Urbanucci A, Martin SE, Khan A, Mathelier A, Thiede B, Walker S, Mills IG (2019)
    High OGT activity is essential for MYC-driven proliferation of prostate cancer cells
    Theranostics, 9 (8), 2183-2197
    DOI 10.7150/thno.30834, PubMed 31149037
11. Jha AK, Neupane P, Pradhan M, Sharma KS, Shrestha S, Sigdel PR, Smeland S, Bruland ØS (2019)
    Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
    J Glob Oncol, 5, 1-10
    DOI 10.1200/JGO.19.00015, PubMed 30917070
12. Jonsson M, Fjeldbo CS, Holm R, Stokke T, Kristensen GB, Lyng H (2019)
    Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer
    Neoplasia, 21 (4), 353-362
    DOI 10.1016/j.neo.2019.01.002, PubMed 30856376
13. Kanduri C, Bock C, Gundersen S, Hovig E, Sandve GK (2019)
    Colocalization analyses of genomic elements: approaches, recommendations and challenges
    Bioinformatics, 35 (9), 1615-1624
    DOI 10.1093/bioinformatics/bty835, PubMed 30307532
14. Lee S, Kolset SO, Birkeland KI, Drevon CA, Reine TM (2019)
    Acute exercise increases syndecan-1 and -4 serum concentrations
    Glycoconj J, 36 (2), 113-125
    DOI 10.1007/s10719-019-09869-z, PubMed 30949875
15. Lund-Andersen C, Nakken S, Nygård S, Fromm B, Aasheim LB, Davidson B, Julsrud L, Abrahamsen TW, Kristensen AT, Dybdahl B, Larsen SG, Hovig E, Flatmark K (2019)
    Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
    Cold Spring Harb Mol Case Stud, 5 (2)
    DOI 10.1101/mcs.a003566, PubMed 30862609
16. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2019)
    Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model
    Acta Oncol, 58 (6), 828-837
    DOI 10.1080/0284186X.2019.1580386, PubMed 30810443
17. Malmström PU, Skaaheim Haug E, Boström PJ, Gudjónsson S, Bjerggaard Jensen J (2019)
    Progress towards a Nordic standard for the investigation of hematuria: 2019
    Scand J Urol, 53 (1), 1-6
    DOI 10.1080/21681805.2018.1555187, PubMed 30636472
18. Nilsen A, Jonsson M, Aarnes EK, Kristensen GB, Lyng H (2019)
    Reference MicroRNAs for RT-qPCR Assays in Cervical Cancer Patients and Their Application to Studies of HPV16 and Hypoxia Biomarkers
    Transl Oncol, 12 (3), 576-584
    DOI 10.1016/j.tranon.2018.12.010, PubMed 30660934
19. Njølstad PR, Andreassen OA, Brunak S, Børglum AD, Dillner J, Esko T, Franks PW, Freimer N, Groop L, Heimer H, Hougaard DM, Hovig E, Hveem K, Jalanko A, Kaprio J, Knudsen GP, Melbye M, Metspalu A, Mortensen PB, Palmgren J, Palotie A, Reed W, Stefánsson H, Stitziel NO, Sullivan PF et al. (2019)
    Roadmap for a precision-medicine initiative in the Nordic region
    Nat Genet, 51 (6), 924-930
    DOI 10.1038/s41588-019-0391-1, PubMed 30988515
20. Pällmann N, Livgård M, Tesikova M, Zeynep Nenseth H, Akkus E, Sikkeland J, Jin Y, Koc D, Kuzu OF, Pradhan M, Danielsen HE, Kahraman N, Mokhlis HM, Ozpolat B, Banerjee PP, Uren A, Fazli L, Rennie PS, Jin Y, Saatcioglu F (2019)
    Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer
    Oncogene, 38 (35), 6301-6318
    DOI 10.1038/s41388-019-0879-2, PubMed 31312022
21. Ree AH, Nygaard V, Russnes HG, Heinrich D, Nygaard V, Johansen C, Bergheim IR, Hovig E, Beiske K, Negård A, Børresen-Dale AL, Flatmark K, Mælandsmo GM (2019)
    Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain
    Cancer Immunol Res, 7 (5), 701-706
    DOI 10.1158/2326-6066.CIR-18-0777, PubMed 30804006
22. Reine TM, Lanzalaco F, Kristiansen O, Enget AR, Satchell S, Jenssen TG, Kolset SO (2019)
    Matrix metalloproteinase-9 mediated shedding of syndecan-4 in glomerular endothelial cells
    Microcirculation, 26 (4), e12534
    DOI 10.1111/micc.12534, PubMed 30703289
23. Sheng X, Nenseth HZ, Qu S, Kuzu OF, Frahnow T, Simon L, Greene S, Zeng Q, Fazli L, Rennie PS, Mills IG, Danielsen H, Theis F, Patterson JB, Jin Y, Saatcioglu F (2019)
    IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling
    Nat Commun, 10 (1), 323
    DOI 10.1038/s41467-018-08152-3, PubMed 30679434
24. Sikkeland J, Lindstad T, Nenseth HZ, Dezitter X, Qu S, Muhumed RM, Ertunc ME, Gregor MF, Saatcioglu F (2019)
    Inflammation and ER stress differentially regulate STAMP2 expression and localization in adipocytes
    Metabolism, 93, 75-85
    DOI 10.1016/j.metabol.2019.01.014, PubMed 30710574
25. Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M (2019)
    A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
    Haematologica, 104 (10), e460-e464
    DOI 10.3324/haematol.2018.209080, PubMed 30846496

Publications 2018

1. Andreassen BK, Grimsrud TK, Haug ES (2018)
   Bladder cancer survival: Women better off in the long run
   Eur J Cancer, 95, 52-58
   DOI 10.1016/j.ejca.2018.03.001, PubMed 29635144
2. Birkeland E, Zhang S, Poduval D, Geisler J, Nakken S, Vodak D, Meza-Zepeda LA, Hovig E, Myklebost O, Knappskog S, Lønning PE (2018)
   Patterns of genomic evolution in advanced melanoma
   Nat Commun, 9 (1), 2665
   DOI 10.1038/s41467-018-05063-1, PubMed 29991680
3. Brunetti M, Gorunova L, Davidson B, Heim S, Panagopoulos I, Micci F (2018)
   Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma
   Oncotarget, 9 (27), 19203-19208
   DOI 10.18632/oncotarget.24969, PubMed 29721194
4. Brynildsen J, Petäjä L, Pettilä V, Nygård S, Vaara ST, Linko R, Okkonen M, Hagve TA, Soininen L, Suojaranta-Ylinen R, Lyngbakken MN, Omland T, Røsjø H (2018)
   The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients
   Clin Biochem, 53, 65-71
   DOI 10.1016/j.clinbiochem.2018.01.012, PubMed 29371002
5. Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ (2018)
   Prognostic markers for colorectal cancer: estimating ploidy and stroma
   Ann Oncol, 29 (3), 616-623
   DOI 10.1093/annonc/mdx794, PubMed 29293881
6. Domingo E, Camps C, Kaisaki PJ, Parsons MJ, Mouradov D, Pentony MM, Makino S, Palmieri M, Ward RL, Hawkins NJ, Gibbs P, Askautrud H, Oukrif D, Wang H, Wood J, Tomlinson E, Bark Y, Kaur K, Johnstone EC, Palles C, Church DN, Novelli M, Danielsen HE, Sherlock J, Kerr D et al. (2018)
   Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
   Lancet Gastroenterol Hepatol, 3 (9), 635-643
   DOI 10.1016/S2468-1253(18)30117-1, PubMed 30042065
7. Dominguez-Valentin M, Evans DGR, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
   Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
   Hered Cancer Clin Pract, 16, 4
   DOI 10.1186/s13053-018-0086-0, PubMed 29371908
8. Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
   Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families
   Fam Cancer, 17 (1), 141-153
   DOI 10.1007/s10689-017-0011-0, PubMed 28608266
9. Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
   Identification of genetic variants for clinical management of familial colorectal tumors
   BMC Med Genet, 19 (1), 26
   DOI 10.1186/s12881-018-0533-9, PubMed 29458332
10. Ebenesersdóttir SS, Sandoval-Velasco M, Gunnarsdóttir ED, Jagadeesan A, Guðmundsdóttir VB, Thordardóttir EL, Einarsdóttir MS, Moore KHS, Sigurðsson Á, Magnúsdóttir DN, Jónsson H, Snorradóttir S, Hovig E, Møller P, Kockum I, Olsson T, Alfredsson L, Hansen TF, Werge T, Cavalleri GL, Gilbert E, Lalueza-Fox C, Walser JW, Kristjánsdóttir S, Gopalakrishnan S et al. (2018)
    Ancient genomes from Iceland reveal the making of a human population
    Science, 360 (6392), 1028-1032
    DOI 10.1126/science.aar2625, PubMed 29853688
11. Fusser M, Øverbye A, Pandya AD, Mørch Ý, Borgos SE, Kildal W, Snipstad S, Sulheim E, Fleten KG, Askautrud HA, Engebraaten O, Flatmark K, Iversen TG, Sandvig K, Skotland T, Mælandsmo GM (2018)
    Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft
    J Control Release, 293, 183-192
    DOI 10.1016/j.jconrel.2018.11.029, PubMed 30529259
12. Gerhauser C, Favero F, Risch T, Simon R, Feuerbach L, Assenov Y, Heckmann D, Sidiropoulos N, Waszak SM, Hübschmann D, Urbanucci A, Girma EG, Kuryshev V, Klimczak LJ, Saini N, Stütz AM, Weichenhan D, Böttcher LM, Toth R, Hendriksen JD, Koop C, Lutsik P, Matzk S, Warnatz HJ, Amstislavskiy V et al. (2018)
    Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
    Cancer Cell, 34 (6), 996-1011.e8
    DOI 10.1016/j.ccell.2018.10.016, PubMed 30537516
13. González Martín A, Oza AM, Embleton AC, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Bertrand MA, Beale P, Cervantes A, Kent E, Kaplan RS, Parmar MKB, Scotto N, Perren TJ, ICON7 investigators (2018)
    Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
    Gynecol Oncol, 152 (1), 53-60
    DOI 10.1016/j.ygyno.2018.08.036, PubMed 30449719
14. Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE (2018)
    Chromatin organisation and cancer prognosis: a pan-cancer study
    Lancet Oncol, 19 (3), 356-369
    DOI 10.1016/S1470-2045(17)30899-9, PubMed 29402700
15. Kleppe A, Danielsen HE (2018)
    Clinical utility of chromatin analysis
    Oncotarget, 9 (65), 32406-32407
    DOI 10.18632/oncotarget.25991, PubMed 30197751
16. Kumar RP, Barkhatov L, Edwin B, Albregtsen F, Elle OJ (2018)
    Portal and Hepatic Vein Segmentation with Leak Restriction: A Pilot Study
    IFMBE PROC, 65, 823-826
    DOI 10.1007/978-981-10-5122-7_206
17. Møller P, Hovig E (2018)
    Retraction Note to: The BRCA2 variant c.68-7 T > A is associated with breast cancer
    Hered Cancer Clin Pract, 16, 10
    DOI 10.1186/s13053-018-0093-1, PubMed 29745381
18. Nielsen B, Kleppe A, Hveem TS, Pradhan M, Syvertsen RA, Nesheim JA, Kristensen GB, Trovik J, Kerr DJ, Albregtsen F, Danielsen HE (2018)
    Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers
    J Natl Cancer Inst, 110 (12), 1400-1408
    DOI 10.1093/jnci/djy063, PubMed 29684152
19. Simonsen TG, Lund KV, Hompland T, Kristensen GB, Rofstad EK (2018)
    DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma
    Int J Radiat Oncol Biol Phys, 102 (4), 1193-1201
    DOI 10.1016/j.ijrobp.2018.04.035, PubMed 29859790
20. Smogeli E, Cvancarova M, Wang Y, Davidson B, Kristensen G, Lindemann K (2018)
    Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only
    Int J Gynecol Cancer, 28 (9), 1789-1795
    DOI 10.1097/IGC.0000000000001356, PubMed 30365455
21. Vaccaro CA, López-Kostner F, Adriana DV, Palmero EI, Rossi BM, Antelo M, Solano A, Carraro DM, Forones NM, Bohorquez M, Lino-Silva LS, Buleje J, Spirandelli F, Abe-Sandes K, Nascimento I, Sullcahuaman Y, Sarroca C, Gonzalez ML, Herrando AI, Alvarez K, Neffa F, Galvão HC, Esperon P, Golubicki M, Cisterna D et al. (2018)
    From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America
    Int J Cancer, 145 (2), 318-326
    DOI 10.1002/ijc.31920, PubMed 30303536
22. Vergote I, Coens C, Nankivell M, Kristensen GB, Parmar MKB, Ehlen T, Jayson GC, Johnson N, Swart AM, Verheijen R, McCluggage WG, Perren T, Panici PB, Kenter G, Casado A, Mendiola C, Stuart G, Reed NS, Kehoe S, EORTC, MRC CHORUS study investigators (2018)
    Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
    Lancet Oncol, 19 (12), 1680-1687
    DOI 10.1016/S1470-2045(18)30566-7, PubMed 30413383
23. Winje IM, Sheng X, Hansson KA, Solbrå A, Tennøe S, Saatcioglu F, Bruusgaard JC, Gundersen K (2018)
    Cachexia does not induce loss of myonuclei or muscle fibres during xenografted prostate cancer in mice
    Acta Physiol (Oxf), 225 (3), e13204
    DOI 10.1111/apha.13204, PubMed 30325108
24. Xu C, Wang Y, Tu Q, Zhang Z, Chen M, Mwangi J, Li Y, Jin Y, Zhao X, Lai R (2018)
    Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation
    Oncogene, 38 (11), 1832-1844
    DOI 10.1038/s41388-018-0556-x, PubMed 30356139

Publications 2017

1. Andreassen BK, Myklebust TÅ, Haug ES (2017)
   Crude mortality and loss of life expectancy of patients diagnosed with urothelial carcinoma of the urinary bladder in Norway
   Scand J Urol, 51 (1), 38-43
   DOI 10.1080/21681805.2016.1271354, PubMed 28084860
2. Bengtsson E, Danielsen H, Treanor D, Gurcan MN, MacAulay C, Molnár B (2017)
   Computer-aided diagnostics in digital pathology
   Cytometry A, 91 (6), 551-554
   DOI 10.1002/cyto.a.23151, PubMed 28640523
3. Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2017)
   Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
   Br J Cancer, 117 (11), 1656-1664
   DOI 10.1038/bjc.2017.346, PubMed 28972967
4. Clancy T, Dannenfelser R, Troyanskaya O, Malmberg KJ, Hovig E, Kristensen V (2017)
   Bioinformatics Approaches to Profile the Tumor Microenvironment for Immunotherapeutic Discovery
   Curr Pharm Des, 23 (32), 4716-4725
   DOI 10.2174/1381612823666170710154936, PubMed 28699527
5. Cyll K, Ersvær E, Vlatkovic L, Pradhan M, Kildal W, Avranden Kjær M, Kleppe A, Hveem TS, Carlsen B, Gill S, Löffeler S, Haug ES, Wæhre H, Sooriakumaran P, Danielsen HE (2017)
   Tumour heterogeneity poses a significant challenge to cancer biomarker research
   Br J Cancer, 117 (3), 367-375
   DOI 10.1038/bjc.2017.171, PubMed 28618431
6. Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B (2017)
   Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma
   Virchows Arch, 471 (3), 355-362
   DOI 10.1007/s00428-017-2172-5, PubMed 28643014
7. de Vries EMG, Färkkilä M, Milkiewicz P, Hov JR, Eksteen B, Thorburn D, Chazouillères O, Pares A, Nygård S, Gilja OH, Wunsch E, Invernizzi P, Carbone M, Bernuzzi F, Boberg KM, Røsjø H, Rosenberg W, Beuers UH, Ponsioen CY, Karlsen TH, Vesterhus M (2017)
   Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study
   Liver Int, 37 (10), 1554-1561
   DOI 10.1111/liv.13402, PubMed 28267887
8. Domanska D, Vodák D, Lund-Andersen C, Salvatore S, Hovig E, Sandve GK (2017)
   The rainfall plot: its motivation, characteristics and pitfalls
   BMC Bioinformatics, 18 (1), 264
   DOI 10.1186/s12859-017-1679-8, PubMed 28521741
9. Helland Å, Brustugun OT, Nakken S, Halvorsen AR, Dønnem T, Bremnes R, Busund LT, Sun J, Lorenz S, Solberg SK, Jørgensen LH, Vodak D, Myklebost O, Hovig E, Meza-Zepeda LA (2017)
   High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
   Int J Cancer, 141 (1), 184-190
   DOI 10.1002/ijc.30726, PubMed 28387924
10. Jin Y, Nenseth HZ, Saatcioglu F (2017)
    Role of PLZF as a tumor suppressor in prostate cancer
    Oncotarget, 8 (41), 71317-71324
    DOI 10.18632/oncotarget.19813, PubMed 29050363
11. Kanduri C, Domanska D, Hovig E, Sandve GK (2017)
    Genome build information is an essential part of genomic track files
    Genome Biol, 18 (1), 175
    DOI 10.1186/s13059-017-1312-1, PubMed 28911336
12. Kildal W, Pradhan M, Cyll K, Jacobsen JE, Kristensen GB, Danielsen HE (2017)
    Characteristics of tumor cell DNA affect prognosis
    Tidsskr. Nor. Laegeforen., 137 (19), 1519-1523
13. Kildal W, Pradhan M, Cyll K, Jacobsen JE, Kristensen GB, Danielsen HE (2017)
    [Properties of cancer cell DNA affects the prognosis]
    Tidsskr Nor Laegeforen, 137 (19)
    DOI 10.4045/tidsskr.16.0966, PubMed 29043733
14. Leske H, Brandal P, Rushing EJ, Niehusmann P (2017)
    IDH-mutant giant cell glioblastoma: A neglected tumor variant?
    Clin Neuropathol, 36 (6), 293-295
    DOI 10.5414/NP301054, PubMed 29035191
15. Lindemann K, Gibbs E, Åvall-Lundqvist E, dePont Christensen R, Woie K, Kalling M, Auranen A, Grenman S, Hoegberg T, Rosenberg P, Skeie-Jensen T, Hjerpe E, Dørum A, Gebski V, Kristensen G (2017)
    Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
    Br J Cancer, 116 (4), 455-463
    DOI 10.1038/bjc.2016.435, PubMed 28118323
16. López-García C, Sansregret L, Domingo E, McGranahan N, Hobor S, Birkbak NJ, Horswell S, Grönroos E, Favero F, Rowan AJ, Matthews N, Begum S, Phillimore B, Burrell R, Oukrif D, Spencer-Dene B, Kovac M, Stamp G, Stewart A, Danielsen H, Novelli M, Tomlinson I, Swanton C (2017)
    BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer
    Cancer Cell, 31 (1), 79-93
    DOI 10.1016/j.ccell.2016.11.001, PubMed 28073006
17. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2017)
    Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer
    Acta Oncol, 56 (5), 675-681
    DOI 10.1080/0284186X.2017.1294762, PubMed 28447564
18. Meisal R, Rounge TB, Christiansen IK, Eieland AK, Worren MM, Molden TF, Kommedal Ø, Hovig E, Leegaard TM, Ambur OH (2017)
    HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization
    PLoS One, 12 (1), e0169074
    DOI 10.1371/journal.pone.0169074, PubMed 28045981
19. Møller P, Hovig E (2017)
    The BRCA2 variant c.68-7 T>A is associated with breast cancer
    Hered Cancer Clin Pract, 15, 20 (Retracted)
    DOI 10.1186/s13053-017-0080-y, PubMed 29158857
20. Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HFA, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M et al. (2017)
    Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
    Gut, 67 (7), 1306-1316
    DOI 10.1136/gutjnl-2017-314057, PubMed 28754778
21. Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2017)
    Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
    BMC Cancer, 17 (1), 29
    DOI 10.1186/s12885-016-2992-8, PubMed 28061772
22. Nygaard V, Rødland EA, Hovig E (2017)
    Reply to Towfic and others' letter to the editor
    Biostatistics, 18 (3), 586-587
    DOI 10.1093/biostatistics/kxx001, PubMed 28334081
23. Ooi J, Wilson P, Walker G, Blaker P, DeMartino S, O'Donohue J, Reffitt D, Lanaspre E, Chang F, Meenan J, Dunn JM (2017)
    Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate
    Endoscopy, 49 (6), 524-528
    DOI 10.1055/s-0043-103410, PubMed 28399610
24. Ooi J, Wilson P, Walker G, Blaker P, DeMartino S, O'Donohue J, Reffitt D, Lanaspre E, Chang F, Meenan J, Dunn JM (2017)
    Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate
    Endoscopy, 49 (6), C1
    DOI 10.1055/s-0043-109623, PubMed 28493237
25. Proctor L, Pradhan M, Leung S, Cheng A, Lee CH, Soslow RA, Gilks CB, Talhouk A, McAlpine JM, Danielsen HE, Hoang LN (2017)
    Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer
    Gynecol Oncol, 146 (3), 596-602
    DOI 10.1016/j.ygyno.2017.06.020, PubMed 28647100
26. Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA, RARECARENet Working Group (2017)
    Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
    Eur J Surg Oncol, 45 (1), 67-74
    DOI 10.1016/j.ejso.2017.09.025, PubMed 29108961
27. Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
    Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
    ESMO Open, 2 (2), e000158
    DOI 10.1136/esmoopen-2017-000158, PubMed 28761742
28. Romaine A, Sørensen IW, Zeltz C, Lu N, Erusappan PM, Melleby AO, Zhang L, Bendiksen B, Robinson EL, Aronsen JM, Herum KM, Danielsen HE, Sjaastad I, Christensen G, Gullberg D (2017)
    Overexpression of integrin α11 induces cardiac fibrosis in mice
    Acta Physiol (Oxf), 222 (2)
    DOI 10.1111/apha.12932, PubMed 28771943
29. Rossi BM, Palmero EI, López-Kostner F, Sarroca C, Vaccaro CA, Spirandelli F, Ashton-Prolla P, Rodriguez Y, de Campos Reis Galvão H, Reis RM, Escremim de Paula A, Capochin Romagnolo LG, Alvarez K, Della Valle A, Neffa F, Kalfayan PG, Spirandelli E, Chialina S, Gutiérrez Angulo M, Castro-Mujica MDC, Sanchez de Monte J, Quispe R, da Silva SD, Rossi NT, Barletta-Carrillo C et al. (2017)
    A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America
    BMC Cancer, 17 (1), 623
    DOI 10.1186/s12885-017-3599-4, PubMed 28874130
30. Røe ÅT, Aronsen JM, Skårdal K, Hamdani N, Linke WA, Danielsen HE, Sejersted OM, Sjaastad I, Louch WE (2017)
    Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy
    Cardiovasc Res, 113 (10), 1161-1172
    DOI 10.1093/cvr/cvx087, PubMed 28472418
31. Seppälä T, Pylvänäinen K, Evans DG, Järvinen H, Renkonen-Sinisalo L, Bernstein I, Holinski-Feder E, Sala P, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Genuardi M, Green K et al. (2017)
    Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report
    Hered Cancer Clin Pract, 15, 18
    DOI 10.1186/s13053-017-0078-5, PubMed 29046738
32. Simovski B, Vodák D, Gundersen S, Domanska D, Azab A, Holden L, Holden M, Grytten I, Rand K, Drabløs F, Johansen M, Mora A, Lund-Andersen C, Fromm B, Eskeland R, Gabrielsen OS, Ferkingstad E, Nakken S, Bengtsen M, Nederbragt AJ, Thorarensen HS, Akse JA, Glad I, Hovig E, Sandve GK (2017)
    GSuite HyperBrowser: integrative analysis of dataset collections across the genome and epigenome
    Gigascience, 6 (7), 1-12
    DOI 10.1093/gigascience/gix032, PubMed 28459977
33. Urbanucci A, Barfeld SJ, Kytölä V, Itkonen HM, Coleman IM, Vodák D, Sjöblom L, Sheng X, Tolonen T, Minner S, Burdelski C, Kivinummi KK, Kohvakka A, Kregel S, Takhar M, Alshalalfa M, Davicioni E, Erho N, Lloyd P, Karnes RJ, Ross AE, Schaeffer EM, Vander Griend DJ, Knapp S, Corey E et al. (2017)
    Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
    Cell Rep, 19 (10), 2045-2059
    DOI 10.1016/j.celrep.2017.05.049, PubMed 28591577
34. Vesterhus M, Holm A, Hov JR, Nygård S, Schrumpf E, Melum E, Thorbjørnsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Røsjø H, Moum B, Ponsioen CY, Boberg KM, Färkkilä M, Karlsen TH, Lund-Johansen F (2017)
    Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
    J Hepatol, 66 (6), 1214-1222
    DOI 10.1016/j.jhep.2017.01.019, PubMed 28161472
35. Vistad I, Bjørge L, Solheim O, Fiane B, Sachse K, Tjugum J, Skrøppa S, Bentzen AG, Stokstad T, Iversen GA, Salvesen HB, Kristensen GB, Dørum A (2017)
    A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway
    Acta Obstet Gynecol Scand, 96 (10), 1162-1169
    DOI 10.1111/aogs.13199, PubMed 28795770
36. Winther JA, Brynildsen J, Høiseth AD, Strand H, Følling I, Christensen G, Nygård S, Røsjø H, Omland T (2017)
    Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study
    Respir Res, 18 (1), 184
    DOI 10.1186/s12931-017-0665-z, PubMed 29100503
37. Zeki SS, Ooi J, Wilson P, Walker G, Blaker P, DeMartino S, O'Donohue J, Reffitt D, Lanaspre E, Chang F, Meenan J, Dunn JM (2017)
    Reply to Westerveld et al. and Schembri et al
    Endoscopy, 49 (11), 1115
    DOI 10.1055/s-0043-118217, PubMed 29073698

Publications 2016

1. Alver TN, Lavelle TJ, Longva AS, Øy GF, Hovig E, Bøe SL (2016)
   MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma
   Oncotarget, 7 (34), 55128-55140
   DOI 10.18632/oncotarget.10422, PubMed 27391157
2. Andreassen R, Rangnes F, Sivertsen M, Chiang M, Tran M, Worren MM (2016)
   Discovery of miRNAs and Their Corresponding miRNA Genes in Atlantic Cod (Gadus morhua): Use of Stable miRNAs as Reference Genes Reveals Subgroups of miRNAs That Are Highly Expressed in Particular Organs
   PLoS One, 11 (4), e0153324
   DOI 10.1371/journal.pone.0153324, PubMed 27128807
3. Björklund AT, Clancy T, Goodridge JP, Béziat V, Schaffer M, Hovig E, Ljunggren HG, Ljungman PT, Malmberg KJ (2016)
   Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
   J Immunol, 196 (3), 1400-11
   DOI 10.4049/jimmunol.1501434, PubMed 26746188
4. Clancy T, Hovig E (2016)
   Profiling networks of distinct immune-cells in tumors
   BMC Bioinformatics, 17 (1), 263
   DOI 10.1186/s12859-016-1141-3, PubMed 27377892
5. Davidson B, Kjæreng ML, Førsund M, Danielsen HE, Kristensen GB, Abeler VM (2016)
   Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma
   Am J Clin Pathol, 145 (4), 449-58
   DOI 10.1093/ajcp/aqw030, PubMed 27149024
6. Ferrante L, Rognum TO, Vege Å, Nygård S, Opdal SH (2016)
   Altered gene expression and possible immunodeficiency in cases of sudden infant death syndrome
   Pediatr Res, 80 (1), 77-84
   DOI 10.1038/pr.2016.45, PubMed 26959483
7. Fjeldbo CS, Julin CH, Lando M, Forsberg MF, Aarnes EK, Alsner J, Kristensen GB, Malinen E, Lyng H (2016)
   Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
   Clin Cancer Res, 22 (16), 4067-76
   DOI 10.1158/1078-0432.CCR-15-2322, PubMed 27012812
8. Fjeldbo CS, Aarnes EK, Malinen E, Kristensen GB, Lyng H (2016)
   Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients
   PLoS One, 11 (5), e0156259
   DOI 10.1371/journal.pone.0156259, PubMed 27244197
9. Halvorsen AR, Silwal-Pandit L, Meza-Zepeda LA, Vodak D, Vu P, Sagerup C, Hovig E, Myklebost O, Børresen-Dale AL, Brustugun OT, Helland Å (2016)
   TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
   Front Genet, 7, 85
   DOI 10.3389/fgene.2016.00085, PubMed 27242894
10. Holmen S, Galappaththi-Arachchige HN, Kleppa E, Pillay P, Naicker T, Taylor M, Onsrud M, Kjetland EF, Albregtsen F (2016)
    Characteristics of Blood Vessels in Female Genital Schistosomiasis: Paving the Way for Objective Diagnostics at the Point of Care
    PLoS Negl Trop Dis, 10 (4), e0004628
    DOI 10.1371/journal.pntd.0004628, PubMed 27073857
11. Hveem TS, Kleppe A, Vlatkovic L, Ersvær E, Wæhre H, Nielsen B, Kjær MA, Pradhan M, Syvertsen RA, Nesheim JA, Liestøl K, Albregtsen F, Danielsen HE (2016)
    Chromatin changes predict recurrence after radical prostatectomy
    Br J Cancer, 114 (11), 1243-50
    DOI 10.1038/bjc.2016.96, PubMed 27124335
12. Hveem TS, Njølstad TS, Nielsen B, Syvertsen RA, Nesheim JA, Kjæreng ML, Kildal W, Pradhan M, Marcickiewicz J, Tingulstad S, Staff AC, Haugland HK, Eraker R, Oddenes K, Rokne JA, Tjugum J, Lode MS, Amant F, Werner HM, Bjørge L, Albregtsen F, Liestøl K, Salvesen HB, Trovik J, Danielsen HE et al. (2016)
    Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer
    Cancer Epidemiol Biomarkers Prev, 26 (1), 61-67
    DOI 10.1158/1055-9965.EPI-16-0215, PubMed 27587790
13. Haakensen VD, Nygaard V, Greger L, Aure MR, Fromm B, Bukholm IR, Lüders T, Chin SF, Git A, Caldas C, Kristensen VN, Brazma A, Børresen-Dale AL, Hovig E, Helland Å (2016)
    Subtype-specific micro-RNA expression signatures in breast cancer progression
    Int J Cancer, 139 (5), 1117-28
    DOI 10.1002/ijc.30142, PubMed 27082076
14. Kummen M, Holm K, Anmarkrud JA, Nygård S, Vesterhus M, Høivik ML, Trøseid M, Marschall HU, Schrumpf E, Moum B, Røsjø H, Aukrust P, Karlsen TH, Hov JR (2016)
    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
    Gut, 66 (4), 611-619
    DOI 10.1136/gutjnl-2015-310500, PubMed 26887816
15. Lindemann K, Kristensen G, Mirza MR, Davies L, Hilpert F, Romero I, Ayhan A, Burges A, Rubio MJ, Raspagliesi F, Huizing M, Creemers GJ, Lykka M, Lee CK, Gebski V, Pujade-Lauraine E (2016)
    Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial
    Ann Oncol, 27 (8), 1505-10
    DOI 10.1093/annonc/mdw238, PubMed 27407100
16. Lyngbakken MN, Røsjø H, Holmen OL, Nygård S, Dalen H, Hveem K, Omland T (2016)
    Gender, High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trøndelag Health Study)
    Am J Cardiol, 118 (6), 816-821
    DOI 10.1016/j.amjcard.2016.06.043, PubMed 27453509
17. Lyngbakken MN, Skranes JB, de Lemos JA, Nygård S, Dalen H, Hveem K, Røsjø H, Omland T (2016)
    Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study)
    Circulation, 134 (24), 1962-1972
    DOI 10.1161/CIRCULATIONAHA.116.023726, PubMed 27815376
18. Munkley J, Vodak D, Livermore KE, James K, Wilson BT, Knight B, Mccullagh P, Mcgrath J, Crundwell M, Harries LW, Leung HY, Robson CN, Mills IG, Rajan P, Elliott DJ (2016)
    Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability
    EBioMedicine, 8, 103-116
    DOI 10.1016/j.ebiom.2016.04.018, PubMed 27428423
19. Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Green K, Lalloo F, Sunde L, Mints M et al. (2016)
    Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
    Gut, 66 (9), 1657-1664
    DOI 10.1136/gutjnl-2016-311403, PubMed 27261338
20. Olsen TK, Panagopoulos I, Gorunova L, Micci F, Andersen K, Kilen Andersen H, Meling TR, Due-Tønnessen B, Scheie D, Heim S, Brandal P (2016)
    Novel fusion genes and chimeric transcripts in ependymal tumors
    Genes Chromosomes Cancer, 55 (12), 944-953
    DOI 10.1002/gcc.22392, PubMed 27401149
21. Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R (2016)
    Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
    Clin Nutr, 36 (3), 672-679
    DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859
22. Ruhlmann CH, Christensen TB, Dohn LH, Paludan M, Rønnengart E, Halekoh U, Hilpert F, Feyer P, Kristensen G, Hansen O, Keefe D, Herrstedt J (2016)
    Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
    Lancet Oncol, 17 (4), 509-518
    DOI 10.1016/S1470-2045(15)00615-4, PubMed 26952945
23. Sikkeland J, Sheng X, Jin Y, Saatcioglu F (2016)
    STAMPing at the crossroads of normal physiology and disease states
    Mol Cell Endocrinol, 425, 26-36
    DOI 10.1016/j.mce.2016.02.013, PubMed 26911931
24. Silva MP, Barros-Silva JD, Ersvær E, Kildal W, Hveem TS, Pradhan M, Vieira J, Teixeira MR, Danielsen HE (2016)
    Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG
    Transl Oncol, 9 (6), 575-582
    DOI 10.1016/j.tranon.2016.08.005, PubMed 27916292
25. Smogeli E, Davidson B, Cvancarova M, Holth A, Katz B, Risberg B, Kristensen G, Lindemann K (2016)
    L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
    BMC Cancer, 16, 596
    DOI 10.1186/s12885-016-2631-4, PubMed 27488577
26. Sorio R, Roemer-Becuwe C, Hilpert F, Gibbs E, García Y, Kaern J, Huizing M, Witteveen P, Zagouri F, Coeffic D, Lück HJ, González-Martín A, Kristensen G, Levaché CB, Lee CK, Gebski V, Pujade-Lauraine E, AURELIA Investigators (2016)
    Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial
    Gynecol Oncol, 144 (1), 65-71
    DOI 10.1016/j.ygyno.2016.11.006, PubMed 27871723
27. Späth F, Andersson U, Dahlin AM, Langseth H, Hovig E, Johannesen TB, Grankvist K, Björkblom B, Wibom C, Melin B (2016)
    Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study
    Tumour Biol, 37 (8), 11065-72
    DOI 10.1007/s13277-015-4742-y, PubMed 26906551
28. Storm M, Sheng X, Arnoldussen YJ, Saatcioglu F (2016)
    Prostate cancer and the unfolded protein response
    Oncotarget, 7 (33), 54051-54066
    DOI 10.18632/oncotarget.9912, PubMed 27303918
29. Tesikova M, Dezitter X, Nenseth HZ, Klokk TI, Mueller F, Hager GL, Saatcioglu F (2016)
    Divergent Binding and Transactivation by Two Related Steroid Receptors at the Same Response Element
    J Biol Chem, 291 (22), 11899-910
    DOI 10.1074/jbc.M115.684480, PubMed 27056330
30. Trillsch F, Mahner S, Hilpert F, Davies L, García-Martínez E, Kristensen G, Savarese A, Vuylsteke P, Los M, Zagouri F, Gladieff L, Sehouli J, Khoon Lee C, Gebski V, Pujade-Lauraine E (2016)
    Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial
    Ann Oncol, 27 (9), 1733-9
    DOI 10.1093/annonc/mdw236, PubMed 27287207
31. Tunsjø HS, Kalyanasundaram S, Worren MM, Leegaard TM, Moen AEF (2016)
    High frequency of occupied attB regions in Norwegian Staphylococcus aureus isolates supports a two-step MRSA screening algorithm
    Eur J Clin Microbiol Infect Dis, 36 (1), 65-74
    DOI 10.1007/s10096-016-2771-0, PubMed 27638009